Rosalind Advisors »

Regentis Biomaterials shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Regentis Biomaterials shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Regentis Biomaterials

Tip: Access up to 7 years of quarterly data

All positions including Regentis Biomaterials held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regentis Biomaterials by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 252k 6.74

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Savara (SVRA)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Miragen Therapeutics (VRDN)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Replimune Group (REPL)
Atyr Pharma (ATYR)
Cybin Com New (HELP)
Eyepoint Pharmaceuticals Com New (EYPT)
Cg Oncology (CGON)
Cytokinetics Com New (CYTK)
X4 Pharmaceuticals Com New (XFOR)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Regentis Biomaterials

Rosalind Advisors
Warberg Asset Management

View all funds holding Regentis Biomaterials